全文获取类型
收费全文 | 8008篇 |
免费 | 687篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 62篇 |
儿科学 | 376篇 |
妇产科学 | 195篇 |
基础医学 | 1105篇 |
口腔科学 | 35篇 |
临床医学 | 970篇 |
内科学 | 1513篇 |
皮肤病学 | 158篇 |
神经病学 | 894篇 |
特种医学 | 114篇 |
外科学 | 919篇 |
综合类 | 66篇 |
一般理论 | 12篇 |
预防医学 | 1227篇 |
眼科学 | 59篇 |
药学 | 518篇 |
中国医学 | 6篇 |
肿瘤学 | 480篇 |
出版年
2024年 | 24篇 |
2023年 | 170篇 |
2022年 | 227篇 |
2021年 | 503篇 |
2020年 | 307篇 |
2019年 | 463篇 |
2018年 | 476篇 |
2017年 | 345篇 |
2016年 | 325篇 |
2015年 | 306篇 |
2014年 | 456篇 |
2013年 | 506篇 |
2012年 | 812篇 |
2011年 | 763篇 |
2010年 | 321篇 |
2009年 | 248篇 |
2008年 | 503篇 |
2007年 | 414篇 |
2006年 | 353篇 |
2005年 | 316篇 |
2004年 | 268篇 |
2003年 | 214篇 |
2002年 | 197篇 |
2001年 | 16篇 |
2000年 | 5篇 |
1999年 | 18篇 |
1998年 | 27篇 |
1997年 | 17篇 |
1996年 | 19篇 |
1995年 | 12篇 |
1994年 | 12篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 2篇 |
1990年 | 8篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 4篇 |
1986年 | 6篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 5篇 |
1982年 | 2篇 |
1981年 | 4篇 |
1980年 | 2篇 |
1978年 | 2篇 |
1974年 | 2篇 |
1971年 | 1篇 |
1961年 | 1篇 |
1949年 | 1篇 |
排序方式: 共有8709条查询结果,搜索用时 15 毫秒
61.
62.
Erin E. Conners Lakshmi Panagiotakopoulos Megan G. Hofmeister Philip R. Spradling Liesl M. Hagan Aaron M. Harris Jessica S. Rogers-Brown Carolyn Wester Noele P. Nelson Contributors Karina Rapposelli Amy L. Sandul Elisa Choi Carla Coffin Kristen Marks David L. Thomas Su H. Wang 《MMWR Recomm Rep》2023,72(1):1
63.
Chelsea L. Edwards Susanna S. Ng Fabian de Labastida Rivera Dillon Corvino Jessica A. Engel Marcela Montes de Oca Luzia Bukali Teija C.M. Frame Patrick T. Bunn Shashi Bhushan Chauhan Siddharth Sankar Singh Yulin Wang Jinrui Na Fiona H. Amante Jessica R. Loughland Megan S.F. Soon Nicola Waddell Pamela Mukhopadhay Lambros T. Koufariotis Rebecca L. Johnston Jason S. Lee Rachel Kuns Ping Zhang Michelle J. Boyle Geoffrey R. Hill James S. McCarthy Rajiv Kumar Christian R. Engwerda 《The Journal of clinical investigation》2023,133(1)
64.
Sinad Isaacson Konyin Adewumi Jennifer S Smith Carissa Novak Sandra Oketch Megan J Huchko 《The oncologist》2023,28(1):e9
BackgroundCervical cancer screening through self-collected high-risk human papillomavirus (HPV) testing has increased screening uptake, particularly in low-resource settings. Improvement ultimately depends, however, on women with positive results accessing follow-up treatment. Identifying the barriers to timely treatment is needed to tailor service delivery for maximum impact.Materials and MethodsThis qualitative study was conducted within a self-collected HPV screening trial in Migori County, Kenya. HPV-positive women were referred for no-cost cryotherapy treatment at the county hospital. Women not attending within 60 days of receiving HPV-positive results were randomly selected for in-depth interviews (IDIs). IDIs were coded and analyzed to develop an analytical framework and identify treatment barriers.ResultsEighty-one women were interviewed. IDIs showed a poor understanding of HPV and cervical cancer, impacting comprehension of screening results and treatment instructions. All 81 had not undergone treatment but reported intending to in the future. Eight reported seeking treatment unsuccessfully or not qualifying, primarily due to pregnancy. Transportation costs and long distances to the hospital were the most reported barriers to treatment. Other obstacles included work, household obligations, and fear of treatment. Impacts of social influences were mixed; some women reported their husbands prevented seeking treatment, others reported their husbands provided financial or emotional support. Few women experienced peer support.ConclusionsWomen faced many barriers to treatment following HPV screening in rural Kenya. Transportation barriers highlight a need for local treatment capacity or screen-and-treat approaches. Ensuring women understand their results and how to seek treatment is essential to improving cervical cancer screening in low-resource settings. 相似文献
65.
66.
67.
Kristen Chalmers Mia Smith Megan Moreno Faisal Malik 《Journal of diabetes science and technology》2022,16(4):858
Background:The majority of adolescents with type 1 diabetes (T1D) integrate social media engagement into their daily lives. The aim of this study was to explore adolescents’ experiences and perspectives discussing their T1D on social media.Methods:Semi-structured interviews with adolescents with T1D were conducted in person and via telephone. Questions focused on the participant’s experiences utilizing social media to discuss T1D and factors that informed the nature of T1D-related social media engagement. Open coding and thematic content analysis were used to identify emergent themes that aligned with accepted domains of social media affordances.Results:Participants included 35 adolescents with T1D. Adolescents’ experiences related to discussing T1D on social media aligned with four affordances of social media: identity, cognitive, emotional, and social. The identity affordances of social media platforms allowed adolescents to curate online personas that selectively included their diagnosis of T1D, while managing the potential negative emotional and social implications linked to the stigma of T1D. Adolescents who decided to discuss T1D on social media leveraged cognitive affordances by providing and receiving diabetes management advice, emotional affordances by obtaining affirmation from peers, and social affordances by extending their network to include other individuals with T1D.Conclusions:Adolescents with T1D flexibly leverage the affordances offered by social media to access emotional support, information, and identity affirmation resources while navigating stigma-based social consequences. Our findings highlight the value of developing tools to support adolescents with T1D in comfortably discussing and receiving appropriate support about T1D on social media. 相似文献
68.
Megan Smith-Uffen Nicci Bartley Grace Davies Megan Best 《Patient education and counseling》2021,104(6):1325-1334
ObjectivesSingle-gene testing is associated with psycho-social challenges for cancer patients. Genomic testing may amplify these. The aim of this study was to understand patients’ motivations and barriers to pursue cancer genomic testing, to enable healthcare providers to support their patients throughout the testing process and interpretation of test results.MethodsFive databases were searched for original peer reviewed research articles published between January 2001 and September 2018 addressing motivation for genomic cancer testing. QualSyst was used to assess quality.Results182 studies were identified and 17 were included for review. Studies were heterogenous. Both somatic and germline testing were included, and 14 studies used hypothetical scenarios. 3249 participants were analyzed, aged 18 to 94. Most were female and white. The most common diagnoses were breast, ovarian, lung and colorectal cancer. Interest in testing was high. Motivations included ability to predict cancer risk, inform disease management, benefit families, and understand cancer. Barriers included concerns about cost, privacy/confidentiality, clinical utility, and psychological harm.ConclusionsDespite concerns, consumers are interested in cancer genomic testing if it can provide actionable results for themselves and their families.Practice ImplicationsProviders must manage understanding and expectations of testing and translate genetic information into health-promoting behaviours. 相似文献
69.
70.